News

Gregg Jarrett Files Lawsuit Against Major Publishers for Conspiracy

Gregg Jarrett Files Lawsuit Against Major Publishers for Conspiracy

Legal Action Against Major Publishers

Legal analyst and bestselling author Gregg Jarrett has initiated a lawsuit against renowned publishers Simon & Schuster and the literary agency Vigliano Associates. The lawsuit, filed in the Supreme Court, contends that these entities engaged in a conspiracy to misappropriate Jarrett's intellectual property related to his book project, ultimately benefiting themselves financially.

Background of the Case

Gregg Jarrett, noted for his works such as "The Russia Hoax" and "Witch Hunt," collaborated with Simon & Schuster's editor, Natasha Simons, who initially praised his new book idea, anticipating its success in the marketplace. Encouraged by agents David Vigliano and Thomas Flannery, Jarrett partnered with researcher Alex Marlow, unaware that Marlow was also represented by Vigliano Associates.

Allegations of Betrayal

In the lawsuit, Jarrett details a severe breach of trust and loyalty by his agents, suggesting that their actions undermined the relationship intrinsic to author-agent dynamics. Lead counsel William A. Brewer III remarked, "This case highlights a betrayal where those meant to support Jarrett's work allegedly conspired against him for personal gain. The actions taken seem to directly contradict the expected duties of fiduciary agents."

The Impact on Jarrett's Project

Initially, Jarrett received interest from the publisher; however, the advance offered was significantly lower than standard publishing rates—less than half of what he earned for prior works. This diminished offer effectively stalled the publication process. Despite assurances from his agents that his project would be marketed elsewhere, an unexpected turn of events soon followed.

Jarrett described feeling blindsided when he received a vague warning about a similar book in production. Following this was a written apology from Flannery, which acknowledged that after Jarrett turned down the offer, they had pitched his concept to Marlow, who agreed to pursue the material. This subsequent book, titled "Breaking the Law," is now scheduled for publication.

Jarrett's Perspective

Reflecting on his intentions, Jarrett stated, "My proposal aimed to elucidate significant political and legal developments affecting our nation, particularly the ongoing lawfare against President Trump. I believe my project was co-opted without my knowledge or consent, which is both disappointing and disturbing."

Legal Relief Sought

Seeking redress for what he describes as significant wrongs, Jarrett's lawsuit demands monetary damages, restitution of profits, and a full accounting of the earnings related to the book that shares the narrative he initially conceived.

The Role of Vigliano Associates

Throughout this situation, Jarrett expressed discontent with Vigliano Associates, stating that they were meant to be his advocates rather than adversaries. "This lawsuit is an effort to bring transparency to an alarming situation and to uphold the rights of authors universally," he remarked.

Understanding the Implications

This lawsuit underscores serious issues within the publishing industry regarding trust, creativity, and the exploitation of authors' works. As a prominent figure, Jarrett's experience may highlight challenges faced by many writers in securing their intellectual property against potential infringements.

Conclusion

This unfolding legal drama serves as an important reminder of the necessity for authors to safeguard their creative works and the potential pitfalls of partnerships that are intended to be collaborative. As the case progresses, it will undoubtedly prompt discussions around authorship rights and the ethical responsibilities of literary agents and publishers.

Frequently Asked Questions

What is the lawsuit about?

The lawsuit involves Gregg Jarrett accusing Simon & Schuster and Vigliano Associates of conspiring to misappropriate his book project.

Who is Gregg Jarrett?

Gregg Jarrett is a bestselling author and legal analyst, known for his insightful commentary on political and legal matters.

What do Jarrett's allegations suggest about the publishing industry?

The allegations raise concerns about breaches of trust and loyalty between authors and their representatives, highlighting a need for greater integrity in publishing practices.

What damages is Jarrett seeking in the lawsuit?

Jarrett is seeking monetary damages, restitution of profits, and an accounting of earnings from the book purportedly based on his original idea.

Why is this case significant?

This case is significant as it sheds light on the potential exploitation of authors and emphasizes the importance of protecting intellectual property rights in the publishing industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

CRMLS Partners with Rayse to Enhance Agent-Client Transparency

Updated Category News Views 108

CRMLS Enhances Agent Value with Rayse Platform California Regional MLS (CRMLS), the leading multiple listing service in the nation, has made a significant move by integrating Rayse, a state-of-the-art agent value platform, into its offerings. This collaboration allows all CRMLS agent users to access Rayse at no cost directly through their MLS dashboard, marking a pivotal...

Continue Reading
UMG & TikTok's New Deal: A Boon for Artists?

Updated Category News Views 8

A New Era for Music Collaboration Universal Music Group and TikTok just cranked up the volume on their alliance, announcing a fresh, multi-year licensing agreement. This ain't just another handshake—it signals a seismic shift in how music gets discovered and consumed globally. Strengthened Bonds and Broadened Horizons Under this new agreement, TikTok will offer its...

Continue Reading
How an Investment in Thermo Fisher Scientific Transforms Wealth

Updated Category News Views 425

Unveiling the Growth of Thermo Fisher Scientific Investing is often seen as a pathway to wealth, and for those who placed their trust in Thermo Fisher Scientific Inc. (NYSE: TMO) two decades ago, the rewards have been substantial. This company, which specializes in scientific instrumentation, reagents, and consumables, has consistently outperformed the market. 20 Years of...

Continue Reading
European Energy A/S Launches Tender Offer for Green Bonds

Updated Category News Views 63

European Energy A/S Announces Its Tender Offer European Energy A/S has officially informed the market about a new opportunity for its bondholders. The company is targeting holders of its existing senior unsecured green bonds due in 2025 and 2026, inviting them to tender their bonds as part of a strategic financing move. Tender Offer Details Under this tender offer, which...

Continue Reading
Building a Rehabilitation Hospital: Encompass and BSA Join Forces

Updated Category News Views 170

Encompass Health and BSA Health System Join Forces Encompass Health Corp. and BSA Health System have embarked on a collaborative journey that aims to enhance rehabilitation services for patients recovering from various health challenges. This partnership marks a significant expansion in the healthcare landscape, focusing on providing dedicated rehabilitation care. A...

Continue Reading